Other/unspecified mastoiditis and related conditions

H8_MASTNAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H70.8, H70.9
  • Hospital discharge: ICD-9 3839
  • Hospital discharge: ICD-8 3829|3839
  • Cause of death: ICD-10 H70.8, H70.9
  • Cause of death: ICD-9 3839
  • Cause of death: ICD-8 3829|3839

2 out of 7 registries used, show all original rules.

170

4. Check minimum number of events

None

170

5. Include endpoints

None

170

6. Filter based on genotype QC (FinnGen only)

170

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1654 727 908
Only index persons 1276 608 668
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.03
Only index persons 0.02 0.02 0.03
Median age at first event (years)
Whole population 37.17 38.88 35.47
Only index persons 33.83 36.42 31.47

-FinnGen-

Key figures

All Female Male
Number of individuals 170 82 88
Unadjusted period prevalence (%) 0.03 0.03 0.04
Median age at first event (years) 35.16 33.07 37.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
152
Matched controls
1521
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
38299
ICD-8 Finland
Unspecified otitis media with mastoiditis
+∞
99.1
84
*
H70.9
ICD-10 Finland
Mastoiditis, unspecified
+∞
49.7
45
*
UDC00
NOMESCO Finland
Ear microscopy
17.0
29.2
48
40
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
28.0
26
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
18.1
17
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
14.1
17.5
30
26
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
95.1
15.9
17
*
DC1AD
NOMESCO Finland
Temporalbone CT
+∞
15.9
15
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
+∞
14.8
14
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
13.7
13
*
38399
ICD-8 Finland
Mastoiditis without mention of otitis media, Unspecified
+∞
12.7
12
*
H70.0
ICD-10 Finland
Acute mastoiditis
+∞
10.5
10
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
+∞
10.5
10
*
H70.8
ICD-10 Finland
Other mastoiditis and related conditions
+∞
10.5
10
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
14.7
9.9
16
12
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.0
9.6
91
507
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
9.5
9
*
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
+∞
9.5
9
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
8.9
9.2
19
24
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.1
8.9
61
269
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
53.1
8.8
10
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.6
8.6
43
151
DFF00
NOMESCO Finland
Pure tone audiometry
5.2
8.6
27
61
H66.9
ICD-10 Finland
Otitis media, unspecified
10.4
8.5
16
17
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
+∞
8.4
8
*
H02AB06
ATC
prednisolone; systemic
2.7
8.1
85
484
H65.0
ICD-10 Finland
Acute serous otitis media
84.0
7.5
8
*
4151
FHL
Reoperation for chronic otitis media
+∞
7.3
7
*
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
+∞
7.3
7
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.7
7.3
32
101
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
23.7
6.8
9
*
H02AB04
ATC
methylprednisolone; systemic
3.6
6.7
31
102
UJF32
NOMESCO Finland
Coloscopy
2.7
6.5
50
230
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
72.7
6.5
7
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
72.7
6.5
7
*
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
11.7
6.4
11
10
TDA90
NOMESCO Finland
Removal wax from ear
19.0
6.3
9
5
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
+∞
6.3
6
*
H65.2
ICD-10 Finland
Chronic serous otitis media
+∞
6.3
6
*
ZXE00
NOMESCO Finland
One hour or less
2.4
6.0
69
393

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761536) Microorganisms panel - Urine sediment
44
101
5.53
19.12
4.5
3.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
44
125
4.40
14.53
3.0
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
28
7.96
13.86
2.2
2.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
32
7.35
13.53
3.2
3.2
mmol/l
1.9
2.7
0.70
14
20
(3013290) Carbon dioxide [Partial pressure] in Blood
21
32
7.35
13.53
3.2
3.2
kpa
4.8
5.1
0.89
21
32
(3027315) Oxygen [Partial pressure] in Blood
21
32
7.35
13.53
3.2
3.2
kpa
8.8
8.4
0.46
21
32
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
128
3.90
11.75
5.9
3.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
30
74
4.71
11.70
13.7
5.9
mmol/l
24.6
25.2
0.42
30
74
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
32
99
3.75
9.18
4.4
3.6
mmol/l
1.2
1.2
0.28
26
89
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
36
5.47
8.83
1.6
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
99
587
2.64
8.79
16.1
9.6
e9/l
0.0
0.0
0.22
82
485
(40767503) Oxygen content in Capillary blood by calculation
16
30
5.78
8.38
2.2
2.5
%
18.3
16.1
—
7
12
(3000494) Fungus identified in Specimen by Culture
37
142
3.05
7.50
1.7
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
76
424
2.43
7.32
7.9
5.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
64
341
2.41
6.73
4.5
4.1
estimate
0.0
0.0
0.00
28
114
(3022806) Fractional oxyhemoglobin in Capillary blood
12
21
6.07
6.68
1.9
2.0
%
91.6
91.1
0.11
12
21
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
22
5.79
6.38
3.5
2.5
e9/l
4.1
4.7
0.40
12
22
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
23
5.54
6.10
5.4
3.2
%
59.9
57.7
0.18
12
23
(3041096) Erythrocytes [Presence] in Urine by Automated
65
363
2.28
6.02
3.7
3.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
53
273
2.37
5.90
3.3
2.5
e6/l
7.2
3.9
0.53
45
241
(3002179) Metamyelocytes/100 leukocytes in Blood
25
88
3.16
5.81
5.6
6.1
%
0.4
0.5
—
7
19
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
33
4.53
5.67
1.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
63
357
2.21
5.56
5.5
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
63
357
2.21
5.56
3.9
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
80
502
2.12
5.42
4.1
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
75
467
2.08
5.11
4.2
3.5
e6/l
83.9
74.1
0.07
53
332
(3021440) Promyelocytes/100 leukocytes in Blood
25
95
2.91
5.09
5.5
6.2
%
0.0
0.2
—
7
29
(3035350) Ketones [Presence] in Urine by Test strip
94
639
2.05
5.02
4.0
3.8
estimate
0.0
0.0
0.00
32
117
(3026782) Osmolality of Urine
51
277
2.20
4.91
3.2
2.8
mosm/kgh2o
535.7
550.8
0.18
44
237
(3021601) Nitrite [Presence] in Urine by Test strip
93
642
1.99
4.63
5.0
5.3
estimate
0.0
0.0
0.00
31
118
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
45
3.56
4.44
3.5
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
93
650
1.95
4.39
4.1
3.9
estimate
0.0
0.0
0.00
32
111
(3017181) Myelocytes/100 leukocytes in Blood
25
104
2.65
4.30
5.6
5.8
%
1.1
0.8
—
7
33
(1761868) Lipid panel - Serum or Plasma
68
438
1.92
4.00
3.5
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
49
282
2.04
3.98
1.7
1.7
pmol/l
379.3
461.3
2.36
34
241
(3013707) Erythrocyte sedimentation rate by Westergren method
123
963
2.00
3.97
5.5
4.1
mm/h
14.8
12.3
0.80
108
880
(3025159) Blasts/100 leukocytes in Blood
23
96
2.61
3.93
5.9
6.0
%
0.0
0.0
—
7
25
(3032080) INR in Blood by Coagulation assay
80
548
1.87
3.87
14.8
8.2
inr
1.1
1.3
1.33
45
168
(3030467) Casts [#/volume] in Urine by Automated count
59
368
1.92
3.79
4.0
2.8
e6/l
0.4
0.3
0.21
44
275
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
79
542
1.85
3.78
4.9
3.8
ng/l
27.8
43.9
0.91
62
390
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
12
6.93
3.71
1.5
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
63
405
1.88
3.68
4.0
3.0
e6/l
52.9
208.7
0.48
50
315
(3042631) Mycobacterium sp identified in Specimen
9
17
5.52
3.56
3.2
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
70
472
1.82
3.47
4.1
2.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
36
194
2.09
3.45
2.4
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
114
896
1.83
3.33
5.2
4.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
7
8.83
3.29
1.5
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
37
206
2.02
3.25
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
15
5.54
3.23
1.5
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
32
170
2.09
3.18
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
29
3.60
3.10
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
12
6.03
3.05
4.7
1.8
pg
29.9
30.8
—
7
12
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
21
4.46
3.04
1.4
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
59
397
1.74
2.85
3.1
3.1
—
—
—
0
0
(3013512) EKG study
56
373
1.75
2.80
4.5
4.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
43
265
1.83
2.78
1.6
1.8
mg/l
2.4
1.3
0.34
31
208
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
6
8.54
2.76
1.0
1.2
mmol/l
4.8
1.8
—
5
6
(3002256) Pathology report gross observation
29
157
2.02
2.74
1.3
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
10
6.17
2.72
1.2
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
24
3.90
2.71
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
32
3.26
2.69
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
112
908
1.68
2.62
4.9
3.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
76
559
1.65
2.60
3.4
2.6
ug/l
152.0
116.0
0.70
62
509
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
7
7.31
2.56
1.6
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
7
7.31
2.56
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
11
5.61
2.56
1.7
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
11
5.61
2.56
1.7
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
11
5.61
2.56
1.7
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
11
5.61
2.56
1.7
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
41
256
1.79
2.53
2.3
3.2
mmol/l
2.5
2.5
0.62
36
224
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
12
5.14
2.42
1.7
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
12
5.14
2.42
1.7
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
17
4.25
2.38
1.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
56
389
1.66
2.35
5.0
4.0
ph
7.4
7.4
0.81
24
69
(3006315) Basophils [#/volume] in Blood
86
665
1.59
2.33
7.5
5.8
e9/l
0.0
0.0
0.81
77
582
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
123
2.01
2.25
1.8
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
9
5.68
2.23
1.6
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
9
5.68
2.23
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
9
5.68
2.23
1.0
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
87
680
1.57
2.22
7.5
5.9
e9/l
1.8
2.0
0.42
76
608
(3001604) Monocytes [#/volume] in Blood
85
663
1.56
2.17
7.6
5.8
e9/l
0.6
0.6
0.30
77
577
(40768443) Skin Pathology biopsy report
14
62
2.37
2.14
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
10
5.11
2.08
1.0
1.0
—
—
—
0
0
(4062490)
5
10
5.11
2.08
1.4
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
87
688
1.54
2.06
7.7
5.8
e9/l
0.2
0.2
0.01
78
611
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
48
333
1.62
1.99
2.7
2.0
mg/l
3.3
3.0
0.51
37
292
(40760892) CBC W Ordered Manual Differential panel - Blood
45
308
1.63
1.97
6.3
5.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
51
0.00
1.92
0.0
5.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
140
1245
1.71
1.90
4.7
4.6
mmol/l
6.0
6.0
0.02
107
1123
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
22
3.27
1.90
1.6
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
28
2.95
1.89
1.9
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
87
2.06
1.87
1.5
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
16
80
2.10
1.87
4.0
2.4
ph
7.4
7.4
—
5
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
17
3.62
1.85
1.5
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
16
81
2.08
1.81
4.0
2.4
kpa
4.7
5.0
0.53
16
74
(3024561) Albumin [Mass/volume] in Serum or Plasma
74
577
1.50
1.81
5.3
4.4
g/l
34.4
35.6
0.78
60
534
(40761511) CBC panel - Blood by Automated count
150
1367
1.83
1.76
19.8
13.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
53
387
1.54
1.75
2.1
2.1
u/l
124.9
232.0
1.30
44
367
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
24
3.00
1.74
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
13
3.93
1.72
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
90
1.99
1.72
1.4
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
49
0.00
1.71
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
137
1.79
1.65
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
218
1.64
1.65
1.7
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
26
2.76
1.60
1.0
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
20
3.07
1.59
1.5
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
58
440
1.48
1.58
3.0
3.6
mmol/l
2.4
2.4
0.04
52
383
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
56
423
1.48
1.56
2.7
2.4
u/l
51.0
56.9
0.94
48
388
(3021960) Folate [Moles/volume] in Serum or Plasma
44
317
1.52
1.53
1.8
1.5
nmol/l
16.7
21.5
1.57
34
263
(3013650) Neutrophils [#/volume] in Blood by Automated count
93
778
1.43
1.50
11.7
9.7
e9/l
4.4
4.1
0.65
80
685
(3026493) Urate [Moles/volume] in Serum or Plasma
45
328
1.51
1.48
2.1
2.6
umol/l
11947.7
6484.1
0.19
37
273
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
28
2.56
1.47
2.7
1.1
—
—
—
0
0
(3012544) pH of Venous blood
20
119
1.77
1.45
5.0
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
136
1227
1.54
1.44
21.7
13.4
ml/min/173m2
80.2
81.0
0.16
120
997
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
140
1273
1.57
1.41
4.7
4.4
mmol/l
4.6
4.6
0.13
112
1169
(3007461) Platelets [#/volume] in Blood
155
1446
1.82
1.40
30.7
20.9
e9/l
246.5
243.2
0.23
143
1406
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
139
1263
1.55
1.40
4.7
4.4
mmol/l
1.4
1.5
0.96
112
1145
(3023419) Bacteria identified in Sputum by Culture
5
17
3.00
1.37
1.2
2.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
155
1448
1.80
1.36
30.6
20.9
fl
91.4
91.2
0.20
143
1422
(3023520) Reticulocytes [#/volume] in Blood
19
114
1.75
1.35
5.1
3.0
e9/l
67.8
69.8
0.08
13
90
(3010813) Leukocytes [#/volume] in Blood
155
1449
1.79
1.34
31.1
20.9
e9/l
7.1
6.8
1.18
143
1404
(3035941) MCH [Entitic mass]
155
1449
1.79
1.34
30.5
20.8
pg
30.2
30.3
0.46
143
1422
(3026361) Erythrocytes [#/volume] in Blood
155
1449
1.79
1.34
30.7
20.9
e12/l
4.4
4.5
1.28
142
1404
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
71
575
1.40
1.33
12.8
5.5
mmol/l
1.2
1.2
0.42
62
517
(3000963) Hemoglobin [Mass/volume] in Blood
155
1450
1.78
1.32
31.1
21.0
g/l
131.8
135.2
1.74
144
1422
(3009508) Creatinine [Moles/volume] in Urine
51
390
1.44
1.31
3.8
2.7
mmol/l
7.1
7.5
0.20
32
312
(40768800) Prostate Pathology biopsy report
6
24
2.55
1.31
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
34
2.42
1.31
1.9
2.0
kpa
9.2
7.8
—
8
29
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
18
2.83
1.29
1.4
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
123
1098
1.43
1.28
25.2
17.6
%
13.9
13.7
0.74
111
1077
(3021447) Carbon dioxide [Partial pressure] in Venous blood
19
116
1.72
1.28
4.8
3.7
kpa
5.9
5.7
0.34
19
111
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
49
2.11
1.24
1.6
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
142
1.63
1.22
1.7
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
26
2.35
1.19
5.2
2.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
28
194
1.53
1.16
2.8
2.1
g/l
2.2
2.4
1.15
23
176
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
20
2.54
1.16
3.4
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
134
1224
1.45
1.16
4.3
3.9
mmol/l
1.3
1.2
0.64
110
1108
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
76
635
1.36
1.14
11.1
6.1
mmol/l
1.2
1.2
0.66
46
533
(3011288) Drugs identified in Urine by Screen method
7
30
2.39
1.13
1.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
51
2.02
1.13
1.6
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
40
2.05
1.13
2.1
2.2
mmol/l
23.2
24.7
—
8
31
(3000991) Gas panel - Venous blood
16
97
1.72
1.11
29.2
7.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
100
874
1.35
1.11
3.3
3.0
u/l
72.5
48.6
0.40
85
828
(3009542) Hematocrit [Volume Fraction] of Blood
130
1186
1.41
1.08
21.6
15.3
%
40.3
39.8
0.37
70
848
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
114
1019
1.36
1.08
9.5
7.4
u/l
75.1
79.6
0.64
100
943
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
33
2.17
1.07
1.9
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
45
2.05
1.07
4.9
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
139
1.58
1.06
1.7
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
46
2.01
1.05
1.0
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
52
414
1.37
1.05
3.9
3.2
ng/l
1596.9
1288.3
0.26
40
354
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
68
1.82
1.03
4.1
2.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
140
1298
1.45
1.03
5.1
4.9
mmol/l
2.7
2.7
0.17
110
1183
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
141
1309
1.45
1.03
22.8
14.3
mg/l
23.2
23.1
0.01
127
1033
(3000764) Benzodiazepines [Presence] in Urine
9
48
1.92
1.02
1.0
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
92
801
1.32
1.02
3.2
2.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
17
108
1.64
1.01
27.2
5.6
mmol/l
1.8
1.3
0.26
17
100
(3028300) Cannabinoids [Presence] in Urine
9
49
1.88
1.00
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
49
1.88
1.00
1.0
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
23
2.21
0.98
8.2
3.7
%
0.2
1.9
—
5
17
(3027944) Amphetamines [Presence] in Urine
9
50
1.84
0.98
1.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
50
1.84
0.98
3.3
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
30
0.00
0.98
0.0
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
37
1.93
0.95
1.1
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
106
947
1.32
0.95
4.1
4.1
pmol/l
14.8
14.9
0.05
86
848
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
27
2.27
0.94
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
33
249
1.40
0.91
2.5
1.7
nmol/l
1348.6
1234.9
0.29
16
190
(40758558) Short blood count panel - Blood
42
331
1.36
0.90
10.5
7.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
147
1384
1.46
0.90
12.7
10.4
u/l
27.4
25.9
0.46
134
1334
(3052851) Hemolysis interference index of Serum or Plasma
8
44
1.86
0.87
2.0
3.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
31
1.97
0.85
1.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
42
335
1.34
0.83
1.7
1.6
mmol/l
1.5
1.3
0.40
22
278
(3012516) Albumin [Mass/volume] in Urine
45
363
1.33
0.83
4.0
2.8
mg/l
25.1
55.4
1.25
15
224
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
128
1185
1.32
0.82
6.6
5.9
mmol/mol
39.8
40.1
0.13
104
1096
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
140
1.49
0.81
1.5
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
3.4
—
46.5
—
0
25
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
75
1.65
0.77
1.8
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
55
1.67
0.75
4.7
2.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
25
2.03
0.73
1.8
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
29
223
1.36
0.73
1.9
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
26
1.95
0.71
2.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
41
1.74
0.71
1.0
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
79
699
1.24
0.69
5.9
6.4
umol/l
9.6
11.8
2.27
72
664
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
27
1.88
0.69
1.8
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
22
163
1.40
0.68
1.2
1.3
titre
176.0
659.1
—
5
46
(3024354) Oxygen [Partial pressure] in Venous blood
15
103
1.50
0.67
5.5
2.9
kpa
5.4
4.4
0.96
15
98
(3019550) Sodium [Moles/volume] in Serum or Plasma
141
1335
1.33
0.67
26.3
16.1
mmol/l
139.4
139.6
0.25
129
1292
(3023103) Potassium [Moles/volume] in Serum or Plasma
141
1338
1.32
0.63
26.6
16.2
mmol/l
4.0
4.0
0.15
129
1291
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
49
1.66
0.63
3.1
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
55
472
1.24
0.62
6.1
4.7
ug/l
2.3
2.1
0.08
43
413
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
185
1.35
0.60
1.6
1.6
—
—
—
0
0
(4306422)
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
37
1.64
0.56
1.5
2.1
—
—
—
0
0
(3020891) Body temperature
9
59
1.55
0.56
5.3
4.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
215
1.30
0.55
1.3
1.2
iu/ml
37.7
35.9
—
7
73
(40768804) Tissue Pathology biopsy report
58
511
1.20
0.50
2.3
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
13
94
1.41
0.47
4.4
3.6
ng/l
111.3
79.4
—
7
83
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
7
48
1.48
0.47
1.9
1.7
ug/l
286.0
406.7
—
7
43
(3033658) Prothrombin time (PT) actual/Normal
39
334
1.22
0.45
4.9
3.5
%
94.4
87.2
0.96
39
328
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
59
528
1.18
0.43
2.5
2.2
nmol/l
82.2
77.3
0.58
49
452
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
114
1.35
0.42
2.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
160
0.73
0.42
13.6
8.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
59
1.37
0.41
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
7
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
60
1.35
0.41
4.5
2.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.41
0.0
4.1
—
99.8
—
0
17
(21494434) Karyotype in Bone marrow
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(4268621)
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
71
1.43
0.40
4.9
2.6
%
0.9
1.3
—
10
71
(3020564) Creatinine [Moles/volume] in Serum or Plasma
143
1383
1.21
0.36
23.4
16.4
umol/l
79.3
78.0
0.26
143
1383
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
41
1.48
0.36
1.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
41
1.48
0.36
1.3
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
136
1.28
0.35
2.3
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
44
1.38
0.35
1.7
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
6
45
1.35
0.34
3.0
1.4
—
0.1
—
0
8
(3020682) Albumin/Creatinine [Ratio] in Urine
44
392
1.17
0.34
6.0
3.6
mg/mmol
6.1
8.3
0.28
14
241
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
48
431
1.16
0.33
2.4
3.2
u/l
33.1
31.9
0.11
42
406
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
74
1.37
0.33
1.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
62
1.30
0.28
17.6
7.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
47
427
1.14
0.28
2.3
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
273
1.17
0.27
2.6
2.8
ug/l
0.7
0.7
0.12
23
169
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
122
1176
1.13
0.27
4.8
4.8
mu/l
1.9
1.9
0.18
100
1054
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
23
199
1.18
0.25
1.3
1.3
u/ml
24.4
10.8
—
7
83
(3011397) Hemoglobin [Presence] in Urine by Test strip
33
296
1.14
0.23
4.0
3.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
38
1.33
0.23
1.0
2.2
%
92.4
88.6
—
5
38
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
39
1.29
0.23
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
39
1.29
0.23
1.6
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
220
1.16
0.23
3.9
2.5
e6/l
2.0
1.0
0.30
15
130
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
89
1.25
0.21
4.0
3.9
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
38.0
—
0
5
(40768795) Lymph node Pathology biopsy report
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
12
0.00
0.21
0.0
3.8
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
506.2
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
275.0
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(4146454)
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
14
0.00
0.20
0.0
3.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
90
1.24
0.19
1.3
2.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
204
1.15
0.19
4.0
2.7
e6/l
0.3
1.7
1.41
11
116
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
147
1.17
0.19
2.4
2.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
16
139
1.17
0.17
26.1
6.5
%
95.7
95.1
0.24
16
132
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
75
0.79
0.16
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
10
119
0.83
0.16
6.0
3.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
79
1.15
0.15
1.2
1.3
—
41.2
—
0
6
(3022621) pH of Urine by Test strip
7
89
0.78
0.15
3.4
2.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
26
284
0.90
0.15
1.2
1.2
u/ml
0.7
1.1
—
8
85
(4010399)
8
95
0.83
0.14
1.5
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
11
128
0.85
0.14
2.7
2.7
u/l
28.4
30.7
0.22
11
106
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
105
0.85
0.13
1.8
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
148
0.87
0.13
4.3
5.2
%
33.8
31.8
—
8
89
(3019150) Specific gravity of Urine by Refractometry
31
289
1.09
0.12
4.2
4.1
kg/l
1.0
1.0
—
7
29
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
11
95
1.17
0.12
1.9
2.7
ml/min/173m2
78.8
61.9
—
5
40
(21494755) Public health laboratory ask at order entry panel
11
126
0.86
0.11
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
36
380
0.93
0.10
4.6
4.1
%
22.0
21.7
0.05
17
181
(3007164) IgA [Mass/volume] in Serum or Plasma
28
262
1.08
0.10
1.3
1.4
g/l
2.6
2.6
0.03
17
165
(3000492) Spirometry study
12
108
1.12
0.07
1.7
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
84
0.83
0.07
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
118
1.11
0.07
1.9
1.9
—
—
—
0
0
(4035726)
13
119
1.10
0.06
1.5
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
30
310
0.96
0.03
2.4
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
36
370
0.97
0.03
1.6
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
16
153
1.05
0.01
26.6
6.1
kpa
5.3
5.1
0.41
16
144
(3027801) Oxygen [Partial pressure] in Arterial blood
16
153
1.05
0.01
26.6
6.1
kpa
11.3
11.8
0.24
16
145
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
63
622
1.02
0.01
4.8
4.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
183
1.04
0.01
1.6
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
24
246
0.97
0.00
4.1
3.3
ng/l
261.2
160.6
0.18
14
192
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
52
517
1.01
0.00
2.3
1.9
pmol/l
100.1
94.2
0.46
29
255
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
15.8
—
0
6
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
96
0.93
0.00
3.3
4.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
38.0
—
0
6
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
62
0.97
0.00
2.0
2.4
u/l
36.8
42.5
—
6
54
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
137.4
—
0
5
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.2
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
4.6
—
103.4
—
0
5
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.4
—
225.1
—
0
7
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
5.1
—
55.0
—
0
8
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.3
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
54
0.92
0.00
1.2
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
90
1.00
0.00
1.3
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1610.3
—
0
7
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H8_MASTNAS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_MASTNAS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: H8_MASTNAS – Other/unspecified mastoiditis and related conditions

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data